Inflammation
Internal Receptors
The Central Dogma
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Measures of Central Tendency
Series R—L Circuit Transients
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 29, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Mario Stampanoni Bassi1, Antonietta Gentile2, Ennio Iezzi1
1Unit of Neurology and Neurorehabilitation, IRCCS Neuromed, Pozzilli, Italy.
Activating the TRPV1 receptor reduces the release of inflammatory cytokines in multiple sclerosis (MS) models. This suggests targeting the endovanilloid system could combat neuroinflammation in MS patients.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: